Detalhe da pesquisa
1.
Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas.
Haematologica
; 106(6): 1705-1713, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32414850
2.
Hematopoietic stem cell transplantation for blood cancers in the era of precision medicine and immunotherapy.
Cancer
; 126(9): 1837-1855, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32073653
3.
Checkpoint blockade treatment sensitises relapsed/refractory non-Hodgkin lymphoma to subsequent therapy.
Br J Haematol
; 191(1): 44-51, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32430944
4.
Impact of Treatment Beyond Progression with Immune Checkpoint Blockade in Hodgkin Lymphoma.
Oncologist
; 25(6): e993-e997, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32275786
5.
Outcomes and Toxicities of Programmed Death-1 (PD-1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real-World, Multicenter Retrospective Analysis.
Oncologist
; 24(7): 955-962, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30568021
6.
Accelerating chimeric antigen receptor therapy in chronic lymphocytic leukemia: The development and challenges of chimeric antigen receptor T-cell therapy for chronic lymphocytic leukemia.
Am J Hematol
; 94(S1): S10-S17, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30861173
7.
Outcomes of patients with relapsed/refractory Hodgkin lymphoma progressing after autologous stem cell transplant in the current era of novel therapeutics: A retrospective analysis.
Am J Hematol
; 92(9): 879-884, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28512788
8.
A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma.
Blood Adv
; 7(14): 3516-3529, 2023 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36735393
9.
Impact of cumulative dose of brentuximab vedotin on outcomes of frontline therapy for advanced-stage Hodgkin lymphoma.
Blood Adv
; 7(24): 7485-7493, 2023 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37603594
10.
Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohort.
Blood Adv
; 7(21): 6630-6638, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37595053
11.
Response-Adapted Treatment Strategies in Hodgkin Lymphoma Using PET Imaging.
PET Clin
; 14(3): 353-368, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31084775
12.
Immunotherapy for the Treatment of Hodgkin Lymphoma: An Evolving Paradigm.
Clin Lymphoma Myeloma Leuk
; 18(6): 380-391, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29685424
13.
Cardiovascular complications associated with novel angiogenesis inhibitors: emerging evidence and evolving perspectives.
Trends Cardiovasc Med
; 23(4): 104-13, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23290365